Patent details

300543 Product Name: Vandetanib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300543
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1244647
Status:
SPC in force
Application number:
300543
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Paediatric Extension

SPC Extension Filing Date:
03/05/2017
SPC Extension Agent/Owner Name:
Genzyme Corporation , ir. F.A. Geurts c.s.
SPC Extension Status:
Application Withdrawn
SPC Extension Grant Date:
SPC Extension Request Refusal Date:
SPC Extension Revocation Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/11/749/001-002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
17/02/2012
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
08/08/2012
First Marketing Authorization date:
17/02/2012
Grant date:
27/08/2012
Activation date:
01/11/2020
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
08/08/2012
SPC/SPC Extension Expiration Date:
31/10/2025
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
07/03/2016
 
 

 

Name:
Genzyme Corporation
Address:
500 Kendall Street, 02142, Cambridge, Massachusetts, United States of America (US)

Historical Applicant/holder

From:
08/08/2012
To:
07/03/2016

 

Name:
AstraZeneca AB
Address:
Gobal Intellectual Property, S-151 85, Södertälje, Sweden (SE)

Agent

Name:
ir. F.A. Geurts c.s.
From:
08/08/2012
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
45/20
Publication date:
04/11/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
19/17
Publication date:
10/05/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
MED
Journal edition number:
40/16
Publication date:
05/10/2016
Description:
Other communications

4

Bulletin Heading:
CO
Journal edition number:
27/16
Publication date:
06/07/2016
Description:
Changes in the Netherlands Patent Register

5

Bulletin Heading:
SPC
Journal edition number:
2012/36
Publication date:
05/09/2012
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

6

Bulletin Heading:
SPC
Journal edition number:
2012/33
Publication date:
15/08/2012
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201601250A
Date Registered:
07/03/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Correction of Inscription

Change Kind/ Decision Type:
Based on clerical error
Deed Number:
RC201601251A
Date Registered:
07/03/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
De nieuwe houder na RFC201601250 moet zijn Genzyme Corporation.
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/10/2024
Annual Fee Number:
25
Annual Fee Amount:
2400 Euro
Last Annual Payment Date:
17/10/2023
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
2200 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages File Type
03/08/2017 Outgoing Correspondence Letter confirmation withdrawal 1 PDF /3/4/5/0/0/0400300543/docs/300543_6_outgoingcorrespondence20170804104920762.pdf
30/05/2017 Outgoing Correspondence Letter to applicant 2 PDF /3/4/5/0/0/0400300543/docs/300543_1_outgoingcorrespondence20170601103054792.pdf
26/05/2017 SPC Documents Withdrawal SPC 1 PDF /3/4/5/0/0/0400300543/docs/300543_10_supplprotectioncertificate20200929014805797.pdf
10/05/2017 Outgoing Correspondence Confirmation receipt request for extension 1 PDF /3/4/5/0/0/0400300543/docs/300543_13_135996l505.pdf
03/05/2017 SPC Documents Certificate SPC 1 PDF /3/4/5/0/0/0400300543/docs/300543_0_supplprotectioncertificate20170510120702111.pdf
03/05/2017 SPC Documents Annex SPC 19 PDF /3/4/5/0/0/0400300543/docs/300543_8_supplprotectioncertificate20200929022317326.pdf
03/05/2017 SPC Documents Annex SPC 10 PDF /3/4/5/0/0/0400300543/docs/300543_12_supplprotectioncertificate20200929022528373.pdf
03/05/2017 Application Form First filed application form 3 PDF /3/4/5/0/0/0400300543/docs/300543_14_applicationform20170510120701896.pdf
27/08/2012 Outgoing Correspondence Outgoing Letter 1 PDF /3/4/5/0/0/0400300543/docs/300543_4_outgoingcorrespondence20120827.pdf
27/08/2012 SPC Documents Certificate SPC 1 PDF /3/4/5/0/0/0400300543/docs/300543_9_supplprotectioncertificate20200929021747097.pdf
08/08/2012 Outgoing Correspondence Outgoing Letter 1 PDF /3/4/5/0/0/0400300543/docs/300543_2_outgoingcorrespondence20120808.pdf
08/08/2012 Application Form First filed application form 3 PDF /3/4/5/0/0/0400300543/docs/300543_3_applicationform20120808.pdf
08/08/2012 SPC Documents Marketing Authorization SPC 4 PDF /3/4/5/0/0/0400300543/docs/300543_5_supplprotectioncertificate20200929021410506.pdf
08/08/2012 SPC Documents Summary of the characteristics of the product 33 PDF /3/4/5/0/0/0400300543/docs/300543_7_supplprotectioncertificate20200929020723860.pdf
08/08/2012 SPC Documents Annex SPC 4 PDF /3/4/5/0/0/0400300543/docs/300543_11_supplprotectioncertificate20200929020835974.pdf